HSP-sairaudet, katsaus - kirjallisuusviitteet
Strümpell A: Beitrage zur Pathologie
Nervenkrankheiten 10: 676 – 717, 1880
des
Rückenmarks.
Arch
für
Psychiatrie
und
Lorrain M: Contribution a l´etude de la paraplégie spasmodique familiale. Paris: Steinheil, 1898
Vassilopoulos D et al., The spinal canal in familial spastic paraplegia. Eur. Neurol. 20: 110-114,
1981
Harding AE: Classification of the hereditary ataxias and spastic paraplegias. Lancet i: 1151 – 1155,
1983
Boustany R-M N et al., The autosomal dominant form of ”pure” familial spastic paraplegia: Clinical
findings and linkage analysis of a large pedigree. Neurology 37: 910 – 915, 1987
Claus D et al., Hereditary motor and sensory neuropathies and hereditary spastic paraplegia: a
magnetic stimulation study. Ann Neurol 28: 43 – 49, 1990
Schady W and Sherad A: A quantitative study of sensory function in hereditary spastic paraplegia.
Brain 113: 709 – 720, 1990
Scheltens P et al., A Dutch family with autosomal dominant pure spastic paraparesis (Strümpell´s
disease). Acta Neurol Scand 82: 169 – 173, 1990
Bonneau D et al: X linked spastic paraplegia (SPG2): clinical heteroigenity at a single gene locus. J
Med Genet 30(5): 381 – 384, 1993
Bruyn RPM et al., Autosomal recessive paraparesis with amyotrophy of the hands and feet. Acta
Neurol Scand 87: 443 – 445, 1993
Hazan J et al., Autosomal dominant familial spastic paraplegia is genetically heterogenous and one
locus maps to chromosome 14q. Nat Genet 5: 163 – 167, 1993
Hodes ME et al., Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 15(6): 383 – 394, 1993
Polo JM et al., Hereditary ”pure” spastic paraplegia: a study of nine families. J Neurol Neurosurg
Psychiatry 56: 175 – 181, 1993
Henanti A et al., Linkage of a locus for autosomal dominant familial spastic paraplegia to
chromosome 2p markers. Hum Mol Genet 3: 1867 – 1871, 1994
Henanti A et al., Linkage of "pure" autosomal recessive familial spastic paraplegia to chromosome
8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet 3: 1263 – 1267, 1994
Cambi F et al., X-linked pure familial spastic paraparesis (Characterization of a large kindred with
magnetic resonance imaging studies). Arch Neurol. 52: 665 – 669, 1995
Fink JK et al., Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q.
Am J Hum Genet 56: 188 – 192, 1995
Fink JK et al., Autosomal dominant, familial spastic paraplegia, type I: Clinical and genetic analysis
of a large North American family. Neurology 45: 325 – 331, 1995
Zelnik N et al., Familial spastic paraparesis. Is it a mitochondrial disorder? Pediatr Neurosurg 23:
225 – 226, 1995
Cambi F et al., Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure
hereditary spastic paraplegia. Neurology 46: 1112 – 1117, 1996
1
Dürr A et al., Phenotype of a autosomal dominant spastic paraplegia linked to chromosome 2.
Brain 119: 1487 – 1496, 1996
Fink JK et al., Hereditary spastic paraplegia linked to chromosome 15q: Analysis of candidate
genes. Neurology 46: 835 – 836, 1996
Kobayashi H et al., Extensive genetic heterogeneity in the ”pure” form of autosomal dominant
familial spastic paraplegia (Strümpell´s disease). Muscle&Nerve 19: 1435 – 1438, 1996
Huang S et al., Another pedigree with pure autosomal dominant spastic paraplegia (AD-FSP) from
Tibet mapping to 14q11.2-q24.3. Hum Genet 100: 620 – 623, 1997
Meierkord H et al., ”Complicated” autosomal dominant familial spastic paraplegia is genetically
distinct from ”pure” forms. Arch Neurol 54: 379 – 384, 1997
Webb S et al., Two families with autosomal resessive spastic paraplegia, pigmented maculopaty
and dementia. ? 63: 628 – 632, 1997
Benson KF et al., CAG repeat expansion in autosomal dominant familial spastic paraparesis: novel
expansion in a subset patient. Hum Mol Genet 7(11): 1779 – 1786, 1998
De Michele G et al., A new locus for autosomal recessive hereditary spastic paraplegia maps to
chromosome 16q24.3. Am J Hum Genet 63(1): 135 – 139, 1998
Paternotte C et al., Quality assessment of whole genome mapping data in the refined familial
spastic paraplegia interval on chromosome 14q. Genome Res 8(11): 1216 – 1227, 1998
Sistermans EA et al., Duplication of the proteolipid protein gene is the major cause of PelizaeusMerzbacher disease. Neurology 50: 1749 – 1754, 1998
Webb S and Hutchinson M: Cognitive impairment in families with pure autosomal dominant
hereditary spastic paraparesis. Brain 121: 923-929, 1998
Coutincho P et al., Clinical heterogeneity of autosomal resessive spastic paraplegias. Arch Neurol
56: 943-949, 1999
Fiegelwicz DA and Bird TD (Ed): "Pure" hereditary spastic paraplegias. The story becomes
complicated. Neurology 53: 5 – 7, 1999
Hazan J et al., Spastin, a new AAA protein, is altered in the most frequent form of autosomal
dominant spastic paraplegia. Nature Gen 23: 296 – 303, 1999
Hedera P et al.,Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to
chromosome 8q. Neurology 53: 44 – 50, 1999
Heilig R and Weissenbach J: Spastin, a new AAA protein, is altered in the most frequent form of
autosomal dominant spastic paraparesis. Nature Genet 23: 298 – 303, 1999
Inoue K et al., Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease:
molecular mechanism and phenotypic manifestations. Ann Neurol 45: 624 – 632, 1999
Martinez-Murillo F et al., Genetic localization of a new locus for recessive familial spastic
paraparesis to 15q13-15. Neurology 53: 50 - 56, 1999
Pearce DA: Hereditary spastic paraplegia: mitochondrial metalloproteases of yeast. Hum Genet
104(6): 443 – 448, 1999 – Rev
2
Reid E et al., A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to
chromosome 12q13, and evidence for further genetic heterogeneity. Am J Hum Genet 65(3): 757 –
763, 1999
Reid E et al., The spastic paraplegia SPG10 locus: narrowing of critical region and exclusion of
sodium channel gene SCN8A as a candidate. J Med Genet 38(1): 65 – 67, 2001
Reid E et al., Autosomal dominant spastic paraplegia: refined SPG8 locus and additional genetic
heterogeneity. Neurology 53: 1844 – 1849, 1999
Settasatian C et al., Genomic structure and expression analysis of the spastic paraplegia gene,
SPG7. Hum Genet 105(1 – 2): 139 – 144, 1999
Reid E et al., Autosomal dominant spastic paraplegia. Refined SPG8 locus and additional genetic
heterogeneity. Neurology 53 : 1844 – 1849, 1999
Seri M et al., Genetic mapping to 10q23.3 – q24.4, in a large Italian pedigree, of a new syndrome
showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am
J Hum Genet 64: 586 – 593, 1999
Sivakumar K et al., Novel exon 3B proteolipid protein gene mutation causing late-onset spastic
paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45: 680 – 683,
1999
Byrne PC et al., Age-related cognitive decline in hereditary spastic paraparesis linked to
chromosome 2p. Neurology 54: 1510 – 1517, 2000
Coppola M et al., Identification and characterization if YME1L1, a novel paraplegin-realted gene.
Genomics 66(1): 48- 54, 2000
Dan B et al., Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis.
Neurosci Lett 280: 175 – 178, 2000
Fontaine B et al., A new locus for autosomal dominant pure spastic paraplegia, on chromosome
2q24-q34. Am J Hum Genet 66: 702 – 707, 2000
Hedera P et al., Mitochondrial analysis in autosomal dominant hereditary spastic paraplegia.
Neurology 55: 1991 – 1952, 2000
Henanti A et al., Novel mutations in spastin gene and absence of sorrelation with age at onset
symptoms. Neurology 55: 1388 – 1390, 2000
Hobson GM et al., Mutations in noncoding regions of the proteolipid protein gene in PelizaeusMerzbacher disease. Neurology 55: 1089 – 1096, 2000
Juhola MK et al., The mitochondrial inner membrane AAA metalloprotease family in metazoas.
FEBS Lett 481(2): 91 – 95, 2000 – Rev
Lo Nigro C et al., A refinied physical and transcriptional map of the SPG9 locus on 10q23.3 – q24.2.
Eur J Hum Genet 8(10): 777 – 782, 2000
McDermott C et al., Hereditary spastic paraparesis: a review of new developments. J Neurol
Neuros Psy 69: 150 – 160, 2000
McDermott CJ et al., Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in
northeast England. Neurology 56: 467 – 471, 2000
3
Percy A (Ed): Pelizaeus-Merzbacher disease. Splice sites are nice sites for disease expression.
Neurology 55: 1072 – 1073, 2000
Reid E et al., A locus for autosomal dominant "pure" hereditary spastic paraplegia maps to
chromosome 19q13. Am J Hum Genet 66(2): 728 – 732, 2000
Rocco P et al., Brazilian family with pure autosomal dominant spastic paraplegia maps to 8q:
analysis of muscle beta 1 syntropin. Am J Med Genet 92(2): 122 – 127, 2000
Santorelli FM et al., Intrafamilial variability in hereditary spastic paraplegia associated with an
SPG4 gene mutation. Neurology 55: 702 – 705, 2000
Vazza G et al., A new locus for autosomal recessive spastic paraplegia is associated wit mental
retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28. Am J Hum
Genet 67(2): 504 – 509, 2000
White KD et al., Clinical and pathologic findings in hereditary spastic paraparesis with spastin
mutation. Neurology 55: 89 – 94, 2000
Ashley-Koch A etal., Fine mapping and genetic heterogeneity in the pure form of autosomal
dominant familial spastic paraplegia. Neurogenetics 3(2): 91 – 97, 2001
Higgins JJ et al., An atypical intronic deletion widens the spectrum of mutations in hereditary
spastic paraplegia. Neurology 56(11): 1482 – 1485, 2001
Hughes CA et al., SPG15, a new locus for autosomal recessive complicated HSP on chromosome
14q. Neurology 56: 1230 – 1233, 2001
Kremmidiotis G et al., Molecular and functional analyses of the human and mouse genes encoding
AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein.
Genomics 76(1-3): 58 – 65, 2001
McDermott CJ et al., Paraplegin gene analysis in hereditary spastic paraparesis (HSP). Neurology
56: 467 – 471, 2001
Piemonte F et al., Respiratory chain defects in hereditary spastic paraplegias. Neuromusc Disord
11(6-7): 565 – 569, 2001
Rainier S et al., Hereditary spastic paraplegia linked to chromosome 14q11-q21: reduction …of the
SPG3 locus interval from 5.3 to 2.7 cM. J Med Genet 38(11): E39, 2001
Hansen JJ et al., Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene
encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet ? , 2002
Meijer IA et al., Spectrum of SPG4 mutations in a large collection of North American families with
hereditary spastic paraplegia. Arch Neurol 59: 281 – 286, 2002
4